Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-omics analysis reveals a unique epigenetic signature in <i>MYD88</i> wild-type Waldenström macroglobulinemia.

Haematologica·2025
Same author

Expanded tumor-associated polymorphonuclear myeloid-derived suppressor cells in Waldenstrom macroglobulinemia display immune suppressive activity.

Blood cancer journal·2024
Same author

Multiomics analysis of IgM monoclonal gammopathies reveals epigenetic influence on oncogenesis via DNA methylation.

Blood·2024
Same author

Endoxifen downregulates AKT phosphorylation through protein kinase C beta 1 inhibition in ERα+ breast cancer.

NPJ breast cancer·2023
Same author

MicroRNA and long non-coding RNA analysis in IgM-monoclonal gammopathies reveals epigenetic influence on cellular functions and oncogenesis.

Haematologica·2023
Same author

Editorial: Modulation of T-cell function and survival by the tumor microenvironment.

Frontiers in cell and developmental biology·2023

Related Experiment Video

Updated: Mar 12, 2026

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

2.0K

Bone marrow microenvironment in Waldenstrom's Macroglobulinemia.

Shahrzad Jalali1, Stephen M Ansell1

  • 1Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN, USA.

Best Practice & Research. Clinical Haematology
|November 10, 2016
PubMed
Summary

Waldenstrom Macroglobulinemia (WM) involves malignant lymphoplasmacytic cells in the bone marrow (BM) producing excess IgM. Understanding the BM microenvironment

Keywords:
Waldenstrom Macroglobulinemia

More Related Videos

Bone Marrow-derived Macrophage Production
07:06

Bone Marrow-derived Macrophage Production

Published on: November 22, 2013

75.6K
Isolation and Culture of Bone Marrow-Derived Macrophages from Mice
07:12

Isolation and Culture of Bone Marrow-Derived Macrophages from Mice

Published on: June 23, 2023

7.7K

Related Experiment Videos

Last Updated: Mar 12, 2026

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

2.0K
Bone Marrow-derived Macrophage Production
07:06

Bone Marrow-derived Macrophage Production

Published on: November 22, 2013

75.6K
Isolation and Culture of Bone Marrow-Derived Macrophages from Mice
07:12

Isolation and Culture of Bone Marrow-Derived Macrophages from Mice

Published on: June 23, 2023

7.7K

Area of Science:

  • Hematology
  • Oncology
  • Cell Biology

Background:

  • Waldenstrom Macroglobulinemia (WM) is a low-grade B-cell lymphoma characterized by bone marrow infiltration.
  • WM cells produce monoclonal immunoglobulin M (IgM), potentially causing hyperviscosity.
  • The bone marrow microenvironment plays a crucial role in WM progression.

Purpose of the Study:

  • To review the interactions between WM cells and the bone marrow microenvironment.
  • To elucidate how the bone marrow supports WM cell growth and proliferation.
  • To inform the development of targeted therapeutic strategies for WM.

Main Methods:

  • Review of existing scientific literature on Waldenstrom Macroglobulinemia.
  • Analysis of data concerning WM cell interactions within the bone marrow.
  • Discussion of the cellular and non-cellular components of the bone marrow milieu.

Main Results:

  • The bone marrow microenvironment provides essential signals for WM cell survival and proliferation.
  • Specific cellular and non-cellular elements within the bone marrow contribute to WM pathogenesis.
  • Genomic alterations in WM cells are important, but the BM microenvironment is also critical.

Conclusions:

  • The bone marrow microenvironment is a key factor in Waldenstrom Macroglobulinemia progression.
  • Targeting the WM cell-BM microenvironment interaction could lead to novel therapies.
  • Further research into this interaction is vital for improving WM treatment outcomes.